Status
Conditions
Treatments
About
The use of phenytoin metabolism to produce S-HPPH accounts for more than 85% of its metabolism. This metabolic pathway is mediated by the activity of CYP2C9.
The purpose of the present study is:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,200 participants in 1 patient group
Loading...
Central trial contact
Yoseph Caraco, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal